학술논문

A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
Document Type
Article
Source
In Annals of Oncology November 2012 23(11):2834-2842
Subject
Language
ISSN
0923-7534